Genetics of diabetes and its complications: a comprehensive review
- PMID: 40452079
- PMCID: PMC12128284
- DOI: 10.1186/s13098-025-01748-y
Genetics of diabetes and its complications: a comprehensive review
Abstract
Background: Diabetes mellitus (DM) affects hundreds of millions of people worldwide. Genetic research plays a crucial role in managing diabetes by providing valuable insights into genetic predispositions, facilitating early diagnosis, and enabling personalized treatment strategies. Identification of important genetic markers has paved the way for the creation of targeted therapies, enhancing treatment outcomes and promoting preventive care for both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). The aim of this study is to explore the role of different genes in the development of DM and its related complications.
Methodology: A comprehensive literature search was conducted from October 27 to November 14, 2024, to enlist articles related to genes involved in development of DM and its complications in search engines including PubMed, Medline, Google Scholar, and Scopus. We included original articles, case-control studies, cohort studies, review articles, systematic review, and meta-analysis published between January 1, 2014, and November 14, 2024 in our study.
Results: In T1DM; research has historically concentrated on the role of HLA class II genes. However, recent studies have brought attention to the role of HLA class I genes in the disease's development, suggesting a broader role of genetics than previously understood. CTLA4, IL2RA, and PTPN22, genes were also significantly linked to T1DM. In T2DM; TCF7L2 was found to be the most potent gene for its development among others genes such as LCAT, APOE, FTO. For gestational diabetes mellitus (GDM), MTNR1B, CDKAL1, and IRS1 genes played an important role.
Conclusion: Genetics played an important role in the understanding of DM. Researchers have identified new genetic loci that can serve as diagnostic markers for DM and its associated compilations such as diabetic kidney disease (DKD), diabetic neuropathy (DN), diabetic retinopathy (DR) and cardiovascular diseases (CVDs). TCF7L2 and HLA class II are the strongest risk factors for T2DM and T1DM, respectively. Understanding the genetics of DM and its complications is essential for improving early detection, enhancing treatment outcomes, and developing targeted therapies for DM patients.
Keywords: Diabetes Mellitus; Early diagnosis; Gene wide association studies; Genetics; Gestational Diabetes Mellitus; Insulin Resistance; Personalised healthcare; Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus; Type 3c Diabetes Mellitus.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethical approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures



Similar articles
-
Prevalence of Metabolic Syndrome and Its Risk Factors Influence on Microvascular Complications in Patients With Type 1 and Type 2 Diabetes Mellitus.Cureus. 2024 Mar 4;16(3):e55478. doi: 10.7759/cureus.55478. eCollection 2024 Mar. Cureus. 2024. PMID: 38571859 Free PMC article.
-
A systematic review of the role of renin angiotensin aldosterone system genes in diabetes mellitus, diabetic retinopathy and diabetic neuropathy.J Res Med Sci. 2014 Nov;19(11):1090-8. J Res Med Sci. 2014. PMID: 25657757 Free PMC article. Review.
-
Genetics: Is LADA just late onset type 1 diabetes?Front Endocrinol (Lausanne). 2022 Aug 10;13:916698. doi: 10.3389/fendo.2022.916698. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36034444 Free PMC article.
-
Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation.Front Endocrinol (Lausanne). 2022 Aug 9;13:909874. doi: 10.3389/fendo.2022.909874. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36017317 Free PMC article.
-
The association between interleukin family and diabetes mellitus and its complications: An overview of systematic reviews and meta-analyses.Diabetes Res Clin Pract. 2024 Apr;210:111615. doi: 10.1016/j.diabres.2024.111615. Epub 2024 Mar 19. Diabetes Res Clin Pract. 2024. PMID: 38513987 Review.
References
-
- Kumar A, Gangwar R, Zargar AA, Kumar R, Sharma A. Prevalence of diabetes in India: a review of IDF Diabetes Atlas 10th edition. Curr Diabetes Rev. 2024;20(1):e130423215752. 10.2174/1573399819666230413094200. - PubMed
-
- Kumar R, Saha P, Kumar Y, Sahana S, Dubey A, Prakash O. A review on diabetes mellitus: type1 & type2. World J Pharm Pharm Sci. 2020;9:838–50. 10.20959/wjpps202010-17336.
-
- Sapra A, Bhandari P. Diabetes. In: StatPearls. Treasure Island (FL): StatPearls Publishing; June 21, 2023.
-
- Magliano DJ, Boyko EJ; IDF Diabetes Atlas 10th edition scientific committee. IDF Diabetes Atlas [Internet]. 10th edition. Brussels: International Diabetes Federation; 2021. Table 3.4, Top 10 countries or territories for number of adults (20–79 years) with diabetes in 2021 and 2045. https://www.ncbi.nlm.nih.gov/books/NBK581940/table/ch3.t4/.
-
- Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 [published correction appears in Diabetes Res Clin Pract. 2023;204:110945. 10.1016/j.diabres.2023.110945]. Diabetes Res Clin Pract. 2022;183:109119. 10.1016/j.diabres.2021.109119. - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous